Comparing two blood tests to guide trauma bleeding treatment
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial tests whether a newer, faster blood test (viscoelastic testing) can better guide treatment for bleeding after a severe injury compared to standard blood tests. If you are in the emergency room shortly after a serious trauma, this study may help doctors decide the right treatments to stop bleeding more quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a severe injury from a blunt or penetrating cause, like a car crash or a stab wound.
- You arrive at the emergency room within 3 hours of the injury and within 1 hour of being admitted to the trauma room.
- You have signs of severe bleeding or shock, such as low blood pressure, a fast heart rate, or low red blood cell count, along with other serious injuries like fractures or internal bleeding seen on ultrasound.
- You are not pregnant, have not had a cardiac arrest, and do not have a severe head injury with fixed pupils.
- You have not received blood transfusions or certain blood-clotting medications before arriving at the hospital.
- You are not on blood-thinning medications (like warfarin or DOACs) and do not have a known bleeding disorder.
- You are able to provide consent after the emergency procedure, or a family member can give consent on your behalf.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
This trial tests a standard set of emergency blood transfusions for people with life-threatening bleeding from a serious injury. It aims to improve survival by giving blood products quickly before reaching the hospital.
This trial tests a simpler way to give a drug called tranexamic acid to trauma patients with heavy bleeding. The drug helps blood clot and may reduce bleeding, but it is important to check if the simplified approach is as safe as the standard one.
This study looks at two simple blood test markers (PLR and PNR) to see how well they predict hidden injuries in trauma patients. If you've had a recent injury and your blood is tested in the ER, you may be able to join.
Hear when a new Trauma Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.